Pancreatic cancer, also known as endocrine cancer, is a very dangerous type of cancer that begins in the pancreas. (Cancer starts when rapidly growing abnormal cells in our body start to multiply out of control.) The pancreas is an organ that helps to aid the digestion of fats and proteins. It produces pancreatic enzymes which break down the starch-rich material that we eat. In fact, all of the food that you ingest can be traced back to the work that has been done by the pancreatic enzymes in your digestive system.
There are three distinct types of pancreatic cancer. The first one is called squamous cell carcinoma in situ (SCCIS). This is the least dangerous type and accounts for roughly seventy-five percent of all cases. In this form, the cancer grows directly from the Pancrean pit itself, which is situated deep within the abdomen. The second type is referred to as adenocarcinoma in situ, or ACIS, and develops in areas around the pancreas which are not necessarily contaminated with fluids or blood.
Pancreatic cancer can spread rapidly and may even recur. In its earliest stages it appears to be just a problem with the cells that are located in or around the Pancreas. As it continues to develop, the cancer cells take over the existing Pancreatic enzymes and begin to consume them. If left unchecked, pancreatic cancer can spread to other parts of the body including the liver, lungs, and other organs. As of today, the most common symptoms associated with these types of cancers include weight loss, difficulty in swallowing, excessive sweating, jaundice, abdominal pain, and nausea.
Pancreatic cancer can be diagnosed in two unique ways: with a blood test and/or X-rays. Blood tests are used to detect the presence of Feingold’s Factor (FF), a protein which is produced by pancreatic cancer cells and is present in all patients with pancreas cancer. In addition to the FF test, a blood test called the pancreatic biopsy is also used to detect endocrine cancers which are slightly more advanced than FF. The pancreatic neuroendocrine tumor is the last type of pancreatic cancer found to be capable of spreading outside of the pancreas to other locations in a person’s body.
There are two major types of pancreatic cancer, which can be found inside the abdomen: the ductal carcinoma in situ (DCIS) and the adenocarcinoma in situ (ADIS). The ductal carcinoma in situ is the more common type, which starts out like a white lump in the abdomen. It later begins to slowly push outward and eventually reaches the liver. On the other hand, the adenocarcinoma in situ starts as a small pouch that develops into a cancerous tumor. While both of these conditions can spread to other organs in the abdominal area, the pancreatic cancer is most often found in its early stages, making diagnosis of this condition much easier.
Pancreatic cancer can spread to other parts of the body through different means. Most commonly, it spreads to the liver or other parts of the body through its extramural spread. This means that it has traveled from its original place of origin, most commonly the intestines or a bile duct, to other areas such as the lung or the kidney. However, exocrine pancreatic cancers can also spread to the lungs, liver or even to the gallbladder through an extramural spread. This is considered the most common type of pancreatic cancer.
Pancreatic cancer information summary will usually include some risk factors for the disease, as well as its treatment. The main risk factors for pancreatic cancer are obesity, insulin resistance, use of oral drugs, and history of alcohol abuse. The treatment for this condition varies based on how far advanced it is, how serious it is, and whether any family history of the disease is present. The most common types of treatment include medication, surgery, chemotherapy, and immunotherapy. The effectiveness of these various treatments will depend greatly on the stage that the cancer is at, its location, the severity of symptoms experienced and the general health of the patient.
Pancreatic neuroendocrine disease can be hard to detect initially, because it does not exhibit any abnormalities at an early stage. Only when a cancer grows significantly – either larger or just as a lump – does anyone realize that something is wrong. At this point, a pancreatic cancer information summary will most likely contain more specific details about how to diagnose the disease, how it should be treated and most importantly, how to survive with it. Pancreatic neuroendocrine carcinoma may also be hard to detect due to its size. A lump is usually not enough to determine if a tumor is present, so many tests will be conducted to determine this. If these tests do come up positive, then the patient will need to see their oncologist and undergo treatment immediately.
Oren Zarif – Psychokinesis Treatment
